Abstract
The aim of this review is to provide the reader general and inspiring prospects on recent and promising fields of innovation in oral drug delivery. Nowadays, inventive drug delivery systems vary from geometrically modified and modular matrices, more close to “classic” pharmaceutical manufacturing processes, to futuristic bio micro-electro-mechanical systems (bioMEMS), based on manufacturing techniques borrowed from electronics and other fields. In these technologies new materials and creative solutions are essential designing intelligent drug delivery systems able to release the required drug at the proper body location with the correct release rate. In particular, oral drug delivery systems of the future are expected to have a significant impact on the treatment of diseases, such as AIDS, cancer, malaria, diabetes requiring complex and multi-drug therapies, as well as on the life of patients, whose age and/or health status make necessary a multiple pharmacological approach.
Similar content being viewed by others
References
M. Morishita, and N. A. Peppas. Is the oral route possible for peptide and protein drug delivery? Drug Discov Today. 11:905–910 (2006). doi:10.1016/j.drudis.2006.08.005.
H. Takeuchi, H. Yamamoto, and Y. Kawashima. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev. 47:39–54 (2001). doi:10.1016/S0169-409X(00)00120-4.
N. A. Peppas. Devices based on intelligent biopolymers for oral protein delivery. Int J Pharm. 277:11–7 (2004). doi:10.1016/j.ijpharm.2003.03.001.
C. Damge, C. P. Reis, and P. Maincent. Nanoparticle strategies for the oral delivery of insulin. Expert Opin Drug Deliv. 5:45–68 (2008). doi:10.1517/17425247.5.1.45.
H. Gelband, and A. Seiter. A global subsidy for antimalarial drugs. Am J Trop Med Hyg. 77:219–21 (2007).
R. Lewanczuk, and S. W. Tobe. More medications, fewer pills: combination medications for the treatment of hypertension. Can J Cardiol. 23:573–6 (2007).
P. Colombo, P. Santi, J. Siepmann, G. Colombo, F. Sonvico, A. Rossi, and O. L. Strusi. Swellable and Rigid Matrices: Controlled Release Matrices with Cellulose Ethers. In L. L. Augsburger, and S. W. Hoag (eds.), Pharmaceutical Dosage Forms: Tablets, Vol. 2, Informa Healthcare USA, Inc., New York, 2008, pp. 433–468.
T. D. Reynolds, S. A. Mitchell, and K. M. Balwinski. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev Ind Pharm. 28:457–466 (2002). doi:10.1081/DDC-120003007.
P. Colombo, U. Conte, A. Gazzaniga, and A. La Manna. Drug release modulation by physical restrictions of matrix swelling. Int J Pharm. 63:43–48 (1990). doi:10.1016/0378-5173(90)90099-P.
R. Bettini, D. Acerbi, G. Caponetti, R. Musa, N. Magi, P. Colombo, D. Cocconi, P. Santi, P. L. Catellani, and P. Ventura. Influence of layer position on release kinetics of levodopa methyl ester and carbidopa from three-layer matrix tablets. Eur J Pharm Biopharm. 53:227–232 (2002). doi:10.1016/S0939-6411(01)00238-7.
P. Colombo, R. Bettini, P. Santi, and N. A. Peppas. Swellable matrices for controlled drug delivery: gel-layer behaviour, mechanisms and optimal performance. Pharm Sci Technol Today. 3:198–204 (2000). doi:10.1016/S1461-5347(00)00269-8.
P. Colombo, R. Bettini, P. Santi, and P. L. Catellani. Modular systems for the controlled release of a substance with space and time control. W. I. P. Organization. WO03043601 (2003).
P. Colombo, P. Santi, R. Bettini, O. L. Strusi, F. Sonvico, and G. Colombo. New modules, new assemblage kits and new assemblies for the controlled release of substances. E. P. Office. PCT/EP2006/011661 (2006).
E. Losi, R. Bettini, P. Santi, F. Sonvico, G. Colombo, K. Lofthus, P. Colombo, and N. A. Peppas. Assemblage of novel release modules for the development of adaptable drug delivery systems. J Control Release. 111:212–8 (2006). doi:10.1016/j.jconrel.2005.12.006.
O. L. Strusi, F. Sonvico, R. Bettini, P. Santi, G. Colombo, P. Barata, A. Oliveira, D. Santos, and P. Colombo. Module assemblage technology for floating systems: in vitro flotation and in vivo gastro-retention. J Control Release. 129:88–92 (2008). doi:10.1016/j.jconrel.2008.04.015.
D. A. LaVan, T. McGuire, and R. Langer. Small-scale systems for in vivo drug delivery. Nat Biotechnol. 21:1184–91 (2003). doi:10.1038/nbt876.
A. C. Richards Grayson, R. Scheidt Shawgo, Y. Li, and M. J. Cima. Electronic MEMS for triggered delivery. Adv Drug Deliv Rev. 56:173–84 (2004). doi:10.1016/j.addr.2003.07.012.
M. Staples, K. Daniel, M. J. Cima, and R. Langer. Application of micro- and nano-electromechanical devices to drug delivery. Pharm Res. 23:847–63 (2006).
N. A. Peppas. Devices based on intelligent biopolymers for oral protein delivery. Int J Pharm. 277:11–17 (2004). doi:10.1016/j.ijpharm.2003.03.001.
S. Amer, and W. Badawy. An integrated platform for bio-analysis and drug delivery. Curr Pharm Biotechnol. 6:57–64 (2005).
J. Z. Hilt, and N. A. Peppas. Microfabricated drug delivery devices. Int J Pharm. 306:15–23 (2005). doi:10.1016/j.ijpharm.2005.09.022.
R. J. Jackman, D. C. Duffy, E. Ostuni, N. D. Willmore, and J. M. Whitesides. Fabricating large arrays of microwells with arbitrary dimensions and filling them using discontinuous dewetting. Anal Chem. 70:2280–2287 (1998). doi:10.1021/ac971295a.
J. T. Santini Jr., M. J. Cima, and R. Langer. A controlled-release microchip. Nature. 397:335–338 (1999). doi::10.1038/16898.
S. L. Tao, and T. A. Desai. Microfabricated drug delivery systems: from particles to pores. Adv Drug Deliv Rev. 55:315–28 (2003). doi:10.1016/S0169-409X(02)00227-2.
J. Vandervoort, and A. Ludwig. Microneedles for transdermal drug delivery: a minireview. Front Biosci. 13:1711–5 (2008). doi:10.2741/2794.
S. L. Tao, and T. A. Desai. Gastrointestinal patch systems for oral drug delivery. Drug Discov Today. 10:909–15 (2005). doi:10.1016/S1359-6446(05)03489-6.
Z. Shen, and S. Mitragotri. Intestinal patches for oral drug delivery. Pharm Res. 19:391–395 (2002). doi:10.1023/A:1015118923204.
A. Ahmed, C. Bonner, and T. A. Desai. Bioadhesive microdevices for drug delivery: a feasibility study. Biomed Microdevices. 3:89–96 (2001). doi:10.1023/A:1011489907820.
A. Ahmed, C. Bonner, and T. A. Desai. Bioadhesive microdevices with multiple reservoirs: a new platform for oral drug delivery. J Control Release. 81:291–306 (2002). doi:10.1016/S0168-3659(02)00074-3.
A. B. Foraker, R. J. Walczak, M. H. Cohen, T. A. Boiarski, C. F. Grove, and P. W. Swaan. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm Res. 20:110–6 (2003). doi:10.1023/A:1022211127890.
K. M. Wood, G. M. Stone, and N. A. Peppas. Wheat germ agglutinin functionalized complexation hydrogels for oral insulin delivery. Biomacromolecules. 9:1293–1298 (2008). doi:10.1021/bm701274p.
A. Moglia, A. Menciassi, M. O. Schurr, and P. Dario. Wireless capsule endoscopy: from diagnostic devices to multipurpose robotic systems. Biomed Microdevices. 9:235–43 (2007). doi:10.1007/s10544-006-9025-3.
N. A. Peppas, K. M. Wood, and J. O. Blanchette. Hydrogels for oral delivery of therapeutic proteins. Expert Opinion on Biological Therapy. 4:881–887 (2004). doi:10.1517/14712598.4.6.881.
L. Bromberg. Intelligent hydrogels for the oral delivery of chemotherapeutics. Expert Opin Drug Deliv. 2:1003–1013 (2005). doi:10.1517/17425247.2.6.1003.
M. Shainpoor, and H.-J. Schneider. Intelligent Materials. Royal Society of Chemistry, Cambridge, 2008.
N. A. Peppas, J. Z. Hilt, and J. B. Thomas. Nanothecnology in Therapeutics: Current Technology and Applications. Horizon Scientific Press, Norwich, UK, 2007.
N. A. Peppas, P. Bures, W. Leobandung, and H. Ichikawa. Hydrogels in pharmaceutical formulations. Eur J Pharm Biopharm. 50:27–46 (2000). doi:10.1016/S0939-6411(00)00090-4.
A. Richter, G. Paschew, S. Klatt, J. Lienig, K.-F. Arndt, and H.-J. P. Adler. Review on Hydrogel-based pH Sensors and Microsensors. Sensors. 8:561–581 (2008). doi:10.3390/s8116999.
H. A. Allock, and A. M. A. Ambrosio. Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels. Biomaterials. 17:2295–2302 (1996). doi:10.1016/0142-9612(96)00073-7.
A. Bernkop-Schnurch. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev. 57:1569–1582 (2005). doi:10.1016/j.addr.2005.07.002.
P. J. Flory, and J. Rehner. Statistical mechanisms of cross-linked polymer networks I. Rubber elasticity. J Chem Phys. 11:512–520 (1943). doi:10.1063/1.1723791.
P. J. Flory, and J. Rehner. Statistical mechanisms of cross-linked polymer networks II. Swelling. J Chem Phys. 11:521–526 (1943). doi:10.1063/1.1723792.
N. A. Peppas, and E. W. Merril. Crosslinked poly(vynyl alcohol) hydrogels as swollen elastic networks. J Appl Polym Sci. 21:1763–1770 (1977). doi:10.1002/app.1977.070210704.
L. Brannon-Peppas, and N. A. Peppas. Equilibrium swelling behavior of pH-sensitive hydrogels. Chem Eng Sci. 46:715–722 (1991). doi:10.1016/0009-2509(91)80177-Z.
S. Hirotsu, Y. Hirokawa, and T. Tanaka. Volume-phase transitions of ionized N-isopropyl acrylamide. J Chem Phys. 87:1392–1395 (1987). doi:10.1063/1.453267.
S. K. Vakkalanka, C. S. Brazel, and N. A. Peppas. Temperature and pH-sensitive terpolymersfor modulated delivery of streptokinase. J Biomed Mater Sci-Polym Ed. 8:119–129 (1996).
C. L. Bell, and N. A. Peppas. Water, solute and protein diffusion in physiologically responsive hydrogels of poly(methacrylic acid-g-ethylene glycol). Biomaterials. 17:1203–1218 (1996). doi:10.1016/0142-9612(96)84941-6.
A. M. Lowman, and N. A. Peppas. Complexation graft copolymers as a drug delivery systems. Polym Prep. 38:566–567 (1997).
A. M. Lowman, M. Morishita, M. Kajita, T. Nagai, and N. A. Peppas. Oral delivery of insulin using ph-responsive complexation gels. J Pharm Sci. 88:933–937 (1999). doi:10.1021/js980337n.
K. Nakamura, M. Morishita, J. Ehara, Y. Onuki, T. Yamagata, N. Kamei, A. M. Lowman, N. A. Peppas, and K. Takayma. Key functions in polymer carriers for intestinal absorption of insulin. Int J Pharm. 354:135–42 (2008).
M. Morishita, T. Goto, K. Nakamura, A. M. Lowman, K. Takayama, and N. A. Peppas. Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats. J Control Release. 110:587–94 (2006). doi:10.1016/j.jconrel.2005.10.029.
M. Morishita, T. Goto, N. A. Peppas, J. I. Joseph, M. C. Torjman, C. Munsick, K. Nakamura, T. Yamagata, K. Takayama, and A. M. Lowman. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption. J Control Release. 97:115–24 (2004). doi:10.1016/j.jconrel.2004.03.008.
K. Nakamura, R. J. Murray, J. I. Joseph, N. A. Peppas, M. Morishita, and A. M. Lowman. Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of network morphology on insulin delivery characteristics. J Control Release. 95:589–99 (2004). doi:10.1016/j.jconrel.2003.12.022.
M. Morishita, A. M. Lowman, K. Takayama, T. Nagai, and N. A. Peppas. Elucidation of the mechanism of incorporation of insulin in controlled release systems based on complexation polymers. J Control Release. 81:25–32 (2002). doi:10.1016/S0168-3659(02)00019-6.
A. De Ascentiis, J. L. de Grazia, C. N. Bowman, P. Colombo, and N. A. Peppas. Mucoadhesion of Poly(2-hydroxyethyl methacrylate) is Improved when Linear Poly(ethylene oxide) Chains are Added to the Polymer Network. J Control Release. 33:197–201 (1995). doi:10.1016/0168-3659(94)00087-B.
L. Serra, J. Doménech, and N. A. Peppas. Design of poly(ethylene glycol)-tethered copolymers as novel mucoadhesive drug delivery systems. Eur J Pharm Biopharm. 63:11–18 (2006). doi:10.1016/j.ejpb.2005.10.011.
R. Bettini, P. Colombo, and N. A. Peppas. Solubility effect on drug transport through pH-sensitive, swelling-controlled release systems: Transport of theophylline and metoclopramide monohydrocloride. J Control Release. 37:105–111 (1995). doi:10.1016/0168-3659(95)00069-K.
A. F. Jimenez-Kairuz, D. A. Allemandi, and R. H. Manzo. Equilibrium properties and mechanism of kinetic release of metoclopramide from carbomer hydrogels. Int J Pharm. 250:129–136 (2003). doi:10.1016/S0378-5173(02)00525-2.
J. M. Bermudez, A. F. Jimenez-Kairuz, M. E. Olivera, D. A. Allemandi, and R. H. Manzo. A ciprofloxacin extended release tablet based on swellable drug polyelectrolyte matrices. AAPS PharmSciTech. 9:924–30 (2008).
A. F. Jimenez-Kairuz, J. M. Llabot, D. A. Allemandi, and R. H. Manzo. Swellable drug-polyelectrolyte matrices (SDPM). Characterization and delivery properties. Int J Pharm. 288:87–99 (2005). doi:10.1016/j.ijpharm.2004.09.014.
M. C. Bonferoni, G. Sandri, S. Rossi, F. Ferrari, C. Caramella, C. Aguzzi, and C. Viseras. Polyelectrolyte–drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behavior. Drug Dev Ind Pharm. 1–8 (2008).
M. C. Bonferoni, S. Rossi, F. Ferrari, and C. Caramella. Development of oral controlled-release tablet formulations based on diltiazem-carrageenan complex. Pharm Dev Technol. 9:155–62 (2004). doi:10.1081/PDT-120027428.
C. Aguzzi, M. C. Bonferoni, M. R. Fortich, S. Rossi, F. Ferrari, and C. Caramella. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs. AAPS PharmSciTech. 3:E27 (2002). doi:10.1208/pt030327.
M. C. Bonferoni, S. Rossi, F. Ferrari, G. P. Bettinetti, and C. Caramella. Characterization of a diltiazem-lambda carrageenan complex. Int J Pharm. 200:207–16 (2000). doi:10.1016/S0378-5173(00)00389-6.
M. V. Ramiréz Rigo, D. A. Allemandi, and R. H. Manzo. Swellable drug-polyelectrolyte matrices (SDPM) of alginic acid Characterisation and delivery properties. Int J Pharm. 322:36–43 (2006). doi:10.1016/j.ijpharm.2006.05.025.
D. A. Quiteros, M. V. Ramiréz Rigo, A. F. Jimenez-Kairuz, M. E. Olivera, R. H. Manzo, and D. A. Allemandi. Interaction between a cationic polymetacrylate (Eudragit E100), and ionic drugs. Eur J Pharm Sci. 33:72–79 (2008).
R. Bettini, L. Zanellotti, P. Colombo, M. C. Bonferoni, and C. Caramella. Drug release kinetics and mechanism from drug-lambda carrageenan complexes, 2003 AAPS Annual Meeting, AAPS, Salt Lake City, 2003, pp. W5095.
C. L. Li, L. G. Martini, J. L. Ford, and M. Roberts. The use of hypromellose in oral drug delivery. J Pharm Pharmacol. 57:533–546 (2005). doi:10.1211/0022357055957.
P. Colombo, R. Bettini, and P. Santi. Hydrophilic polymers for matrix systems. In G. G. Barrat, D. Duchene, E. Fattal, and J. Y. Legendre (eds), New trends in polymers for oral and parenteral administration from design to receptors, Edition de Santé, Paris, Paris, 2001, pp. 99–106.
P. Colombo, A. Gazzaniga, U. Conte, M. E. Sangalli, and A. La Manna. Solvent front movement and release kinetics in compressed swellable matrices. Int. Symp. Control. Release Society. 14:83–84 (1987).
U. Conte, P. Colombo, A. Gazzaniga, M. E. Sangalli, and A. La Manna. Swelling activated drug delivery systems. Biomaterials. 9:489–493 (1988). doi:10.1016/0142-9612(88)90043-9.
S. Conti, L. Maggi, L. Segale, E. Ochoa Machiste, U. Conte, P. Grenier, and G. Vergnault. Matrices containing NaCMC and HPMC 1. Dissolution performance characterization. Int J Pharm. 333:136–42 (2007). doi:10.1016/j.ijpharm.2006.11.059.
P. L. Catellani, P. Colombo, N. A. Peppas, P. Santi, and R. Bettini. Partial permselective coating adds an osmotic contribution to drug release from swellable matrixes. J Pharm Sci. 87:726–31 (1998). doi:10.1021/js9800026.
K. J. Edgar. Cellulose esters in drug delivery. Cellulose. 14:49–64 (2007). doi:10.1007/s10570-006-9087-7.
F. Lecomte, J. Siepmann, M. Walther, R. J. MacRae, and R. Bodmeier. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm Res. 22:1129–41 (2005). doi:10.1007/s11095-005-5421-2.
F. Lecomte, J. Siepmann, M. Walther, R. J. Macrae, and R. Bodmeier. pH-sensitive polymer blends used as coating materials to control drug release from spherical beads: importance of the type of core. Biomacromolecules. 6:2074–83 (2005). doi:10.1021/bm0500704.
F. Lecomte, J. Siepmann, M. Walther, R. J. MacRae, and R. Bodmeier. Polymer blends used for the aqueous coating of solid dosage forms: importance of the type of plasticizer. J Control Release. 99:1–13 (2004). doi:10.1016/j.jconrel.2004.05.011.
F. Lecomte, J. Siepmann, M. Walther, R. J. MacRae, and R. Bodmeier. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques. Pharm Res. 21:882–90 (2004). doi:10.1023/B:PHAM.0000026443.71935.cb.
P. W. S. Heng, J. H. Hao, L. W. Chan, and S. H. Chew. Influence of osmotic agents in diffusion layer on drug release from multilayer coated pellets. Drug Dev Ind Pharm. 30:213–220 (2004). doi:10.1081/DDC-120028717.
Acknowledgements
Authors would like to acknowledge Dr. Pedro Barata (Faculdade de Ciências da Saúde, Universidade Fernando Pessoa - Porto, Portugal) and Dr. Orazio Luca Strusi for their precious help in collecting the gamma scintigraphy images.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Colombo, P., Sonvico, F., Colombo, G. et al. Novel Platforms for Oral Drug Delivery. Pharm Res 26, 601–611 (2009). https://doi.org/10.1007/s11095-008-9803-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-008-9803-0